An underground economy for unlicensed slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Experimental Drug Acquiring Traction Via Social Media
Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed fat-burning properties. Followers are urged to message these profiles directly for source information, while also receiving discount codes.
Active Trade on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and claims of rapid UK delivery. Vendors market the substance there before redirecting customers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Professionals Express Concerns
However, doctors and pharmacists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could result in individuals administering substances of uncertain source.
Several experts stated the demand for retatrutide could be connected to the increasing cost of licensed slimming products such as Mounjaro.
Regulatory Position and Enforcement
Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be marketed or supplied for human use under the British medical regulations.
Several content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach pharmaceutical, marketing, and customer laws, potentially leading to penalties, legal action or imprisonment.
Platform Response and Material Elimination
According to TikTok, the service has taken down problematic material and banned related keywords and search suggestions. The company stated it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.
Digital Trading Activities
Investigations also discovered groups with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of members, populated with images of weight loss, glowing testimonials and step-by-step instructions for mixing or administering at home.
After moments of entering one community, a seller shared contact information, where the majority of purchases take place. The vendor sent an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about weight, medical conditions or past usage.
Product Details and Pricing
Within these communities, messages display black plastic packages with postal service stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.
Platform Oversight and Security Measures
A representative for the messaging service stated it actively monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering materials they can’t verify. Although the science behind this drug is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.
Her team has already seen patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject patients to possibly serious medical dangers”.
